secwatch / observer
8-K filed April 9, 2025, 7:59 PM ET ticker PETS CIK 0001040130
leadership confidence high sentiment positive materiality 0.50

PetMed Express appoints Peter Batushansky to Board; Dr. Fulgoni to retire at 2025 annual meeting

PETMED EXPRESS INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Peter Batushansky

Director
PETS · PETMED EXPRESS INC
Effective
2025-04-09
Filed
April 9, 2025, 7:59 PM ET
On April 9, 2025, the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”) approved the appointment of Peter Batushansky to serve as a director of the Company beginning April 9, 2025.
Departed

Gian Fulgoni

Director
PETS · PETMED EXPRESS INC
Filed
April 9, 2025, 7:59 PM ET
Dr. Gian Fulgoni, longtime Board member and former Chairman, has communicated his intention to retire from the Board when his term expires at the 2025 annual shareholders’ meeting.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Peter Batushansky was appointed as Director at PETMED EXPRESS INC.

Action
appointed
Role
Director
Exact text from the filing
On April 9, 2025, the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”) approved the appointment of Peter Batushansky to serve as a director of the Company beginning April 9, 2025.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Gian Fulgoni departed as Director at PETMED EXPRESS INC.

Action
retire
Role
Director
Exact text from the filing
Dr. Gian Fulgoni, longtime Board member and former Chairman, has communicated his intention to retire from the Board when his term expires at the 2025 annual shareholders’ meeting.
View on SEC.gov

PETMED EXPRESS INC filing history →

Source: SEC EDGAR
accession 0001040130-25-000016
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.